Rajeev Saggar
Chief Tech/Sci/R&D Officer at LIQUIDIA CORPORATION
Net worth: 3 M $ as of 30/04/2024
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Roger Jeffs | M | 62 | 4 years | |
Stephen Bloch | M | 62 | 4 years | |
Arthur Kirsch | M | 72 | 4 years | |
Joanna Horobin | M | 69 | 4 years | |
Paul Manning | M | 68 | 4 years | |
Russell Schundler | M | 49 | 3 years | |
Michael Kaseta | M | 48 | 4 years | |
Raman Singh | M | 53 | 4 years | |
David Johnson | M | 41 | 3 years | |
Katherine Rielly-Gauvin | F | 61 | 4 years | |
Damian deGoa | M | 45 | 4 years | |
Scott Moomaw | M | 54 | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert Lippe | M | 59 | 4 years | |
Quentin Langlois | M | - |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | 3 years |
Brihad Abhyankar | M | - |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 15 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rajeev Saggar
- Personal Network